Efficacy of omalizumab in delayed pressure urticaria: a case report

Uloženo v:
Podrobná bibliografie
Vydáno v:Allergy (Copenhagen) Ročník 65; číslo 1; s. 138 - 139
Hlavní autoři: Bindslev-Jensen, C, Skov, P.S
Médium: Journal Article
Jazyk:angličtina
Vydáno: Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.01.2010
Blackwell Publishing Ltd
Témata:
Adult
adverse effects
Anti-Allergic Agents
Anti-Allergic Agents - therapeutic use
Antibodies, Anti-Idiotypic
Antibodies, Monoclonal
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
asthma
basic immunology
basophil
Basophils
Basophils - drug effects
Basophils - immunology
dendritic cells
dermatology
drug allergy
drug effects
drug therapy
etiology
Female
food allergy
Histamine Release
Histamine Release - drug effects
Humans
immunology
Omalizumab
pharmacology
Physical Stimulation
Physical Stimulation - adverse effects
therapeutic use
urticaria
Urticaria - drug therapy
Urticaria - etiology
ISSN:0105-4538, 1398-9995, 1398-9995
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Bibliografie:http://dx.doi.org/10.1111/j.1398-9995.2009.02188.x
We report the first successful treatment of delayed pressure urticaria in 2a patient, unresponsive to conventional treatment.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Case Study-2
ObjectType-Feature-4
ObjectType-Report-1
ObjectType-Article-3
ISSN:0105-4538
1398-9995
1398-9995
DOI:10.1111/j.1398-9995.2009.02188.x